Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Epistaxis
ADR ID BADD_A01528
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.03      Nasal disorders NEC
22.04.03.001      Epistaxis
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.01      Haemorrhages NEC
24.07.01.005      Epistaxis
Description A disorder characterized by bleeding from the nose. [CTCAE] Bleeding from the nose. [MeSH]
MedDRA Code 10015090
MeSH ID D004844; D004844; D004844
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bleeding nose | Epistaxis | Haemorrhage nasal | Hemorrhage nasal | Nasal bleeding | Nasal mucus blood tinged | Nose bleed | Nose bleeds | Nosebleed | Chronic epistaxis | Blood clot in nose | Nasal Bleeding | Bleeding, Nasal | Bleedings, Nasal | Nasal Bleedings | Nose Bleed | Nose Bleeds | Nosebleeds
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D000042-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate--
BADD_D000054-oxo-3-(3-oxo-1-phenylbutyl)chromen-2-olate--
BADD_D000064r,6r-dorzolamide--
BADD_D00016Acamprosate--
BADD_D00017Acamprosate calcium--
BADD_D00033Acetylsalicylic acid0.000387%
BADD_D00036Acitretin--
BADD_D00046Ado-trastuzumab emtansine--
BADD_D00047Afatinib0.001724%
BADD_D00048Aflibercept--
BADD_D00056Albuterol--
BADD_D00064Alemtuzumab--
BADD_D00067Alfentanil--
BADD_D00071Alglucosidase alfa--
BADD_D00073Aliskiren--
BADD_D00076Allopurinol--
BADD_D00077Almotriptan--
BADD_D00078Almotriptan malate--
BADD_D00085Alprazolam--
BADD_D00100Ambrisentan0.014441%
BADD_D00103Amikacin0.000557%
BADD_D00106Aminocaproic acid0.001966%
BADD_D00121Amlodipine--
BADD_D00122Amlodipine besylate--
BADD_D00132Amphotericin b--
BADD_D00139Anagrelide--
BADD_D00140Anagrelide hydrochloride--
BADD_D00147Antihemophilic factor (recombinant)--
BADD_D00151Apixaban0.019984%
BADD_D00161Argatroban0.000181%
The 1th Page    1 2 3 4 5    Next   Last    Total 20 Pages